Rhian Davies, DO
Cardiovascular Disease · York, PANPI 1174899702
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $534,327 of the $853,048 with a category attached, or 62.6%. 32 manufacturers reported payments, led by Shockwave Medical, Inc at 29.8% of the total. 2025 is the largest year on record at $337,082, more than ten times the $8,629 reported in 2019. Among cardiovascular disease clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,001 payments — averaging $852.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$254K
- Teleflex LLC$131K
- Boston Scientific$122K
- Medtronic$119K
- Abiomed$92K
- Siemens Medical Solutions USA, Inc.$41K
- plus $95K from 26 others
Across 43 payments — averaging $4576.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Shockwave Medical, Inc$179K
- Boston Scientific$16K
- M.a. Med Alliance S.A.$2K
What the payments were for
- Consulting fees$164,76319%
- Speaking & faculty fees$534,32763%
- Travel & lodging$94,53511%
- Food & beverage$59,0937%
- Education$3290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 145 | $253,991 |
| Teleflex LLC | 123 | $130,833 |
| Boston Scientific | 173 | $121,811 |
| Medtronic(2 entities) | 214 | $118,895 |
| Abiomed | 90 | $91,732 |
| Siemens Medical Solutions USA, Inc. | 63 | $40,674 |
| Arrow International, Inc. | 21 | $29,519 |
| Asahi Intecc USA, Inc. | 57 | $24,421 |
| Terumo Medical Corporation | 32 | $20,797 |
| Cordis US CORP. | 18 | $13,333 |
| Biotronik Inc. | 8 | $2,962 |
| Abbott | 23 | $983 |
| Verge Medical, Inc. | 3 | $456 |
| Heartflow, Inc. | 1 | $350 |
| W. L. Gore & Associates, Inc. | 3 | $294 |
| Teleflex Medical Canada Inc. | 1 | $290 |
| Asahi Intecc CO., LTD. | 2 | $285 |
| Chiesi USA, Inc. | 2 | $257 |
| Philips North America LLC | 3 | $254 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $194 |
| Edwards Lifesciences | 1 | $185 |
| Reflow Medical Inc | 2 | $101 |
| Avinger Inc. | 2 | $99 |
| ZOLL Circulation Inc | 1 | $85 |
| Biosense Webster, Inc. | 2 | $60 |
| Opsens Inc. | 1 | $40 |
| Inari Medical, Inc. | 2 | $37 |
| Novartis | 2 | $35 |
| Boehringer Ingelheim | 1 | $22 |
| Pfizer | 1 | $19 |
| Stryker | 1 | $18 |
| Amgen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$252,169
- Impella$85,868
- GUIDELINER$81,362
- ONYX FRONTIER$72,079
- GENERAL VASCULAR ACCESS$41,362
- TURNPIKE$37,015
- GUIDELINER V3 CATHETER$31,675
- RESOLUTE ONYX$30,587
- CorPath Imaging System$22,591
- ASAHI PTCA Guide Wire$16,520
- SELUTION SLR PTA$12,036
- GlideWire$11,150
- AVVIGO Guidance System$6,616
- TRAPLINER$6,525
- GENERAL BALLOONS$6,250
- METACROSS OTW$5,565
- PERIPHERAL VASCULAR$5,473
- General - CT_IC$2,620
- GLIDESHEATH SLENDER$2,434
- GENERAL - THERAPIES$2,073
How this compares
$853,048 in reported general payments places this provider in the 95th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prasugrel Hcl | 20 | $1,575 |
| ClopidogrelClopidogrel Bisulfate | 93 | $1,027 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 33 | $548 |
| Atorvastatin Calcium | 15 | $455 |
| Metoprolol Succinate | 21 | $215 |
| Carvedilol | 14 | $59 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in York
- Christopher WengerYork$91K
- Hemal GadaWormleysburg$1.8M
- Benjamin KalsmithPgh$1.7M
- Peter KoweyWynnewood$1.5M
- Paul ForfiaPhiladelphia$1.2M
- Quang BuiPhiladelphia$933K
- Sarang MangalmurtiBryn Mawr$728K
- Sabahat BokhariAllentown$578K
- George GabrielPittsburgh$563K
- Rajesh DaveCamp Hill$442K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.